Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
基本信息
- 批准号:9147250
- 负责人:
- 金额:$ 32.87万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdultAgeAged, 80 and overAgingAneurysmAnimal FeedAnimal ModelAnimalsAortaAtherosclerosisBiological PreservationBlood PressureBlood VesselsCCL2 geneCCRCaloric RestrictionCell AgingCellsCellularityChronicCo-ImmunoprecipitationsCollagenCollagen Type IComplexCrossbreedingDepositionDevelopmentDietDiploidyDiseaseDown-RegulationDoxycyclineEhlers-Danlos SyndromeElastic FiberElastin FiberElderlyEquilibriumExtracellular MatrixFibroblastsFibrosisFoodGelatinase AGelatinase BGelatinasesGenetic TranscriptionHealthHereditary DiseaseHumanHypertensionImmunoblottingIn SituIn VitroIncidenceInfiltrationInflammationInterstitial CollagenaseInterventionLesionLifeLongevityLosartanMADH2 geneMatrix Metalloproteinase InhibitorMatrix MetalloproteinasesMeasuresMediatingMetalloproteasesMolecularMonocyte Chemoattractant Protein-1MusNorwayPatientsPhosphorylationPlayProductionProteinsRattusRecombinantsRisk FactorsRoleSerumSeveritiesSignal PathwaySignal TransductionSignaling MoleculeSmooth Muscle MyocytesTherapeuticTimeTranslationsTriad Acrylic ResinTunica MediaVascular DiseasesWeaningWild Type Mouseagedarterial remodelingarterial stiffnesscell agefeedinghuman TGFB1 proteinin vitro Modelin vivomouse modelnoveloverexpressionpressurepreventproendothelin 1receptorresearch clinical testingsenescencetherapy design
项目摘要
The coincidence of vascular smooth muscle cell (VSMC) infiltration and collagen deposition within a diffusely thickened intima is a salient feature of central arterial wall inflammation that accompanies advancing age. However, the molecular mechanisms involved remain undefined. Immunostaining and immunoblotting of rat aortae demonstrate that a triad of proinflammatory molecules, MCP-1, TGF-β1, and MMP-2 increases within the aortic wall with aging. Exposure of VSMC isolated from 8-mo-old rats (young) to MCP-1 effects, via CCR-2 signaling, produce both an increase in TGF-β1 activity, up to levels of untreated VSMC from 30-mo-old (old) rats, and a concurrent increase in MMP-2 activation. Furthermore, exposure of young VSMC to TGF-β1 increases levels of MCP-1, and MMP-2 activation, to levels of untreated VSMC from old rats. This autocatalytic signaling loop that enhances collagen production and invasiveness of VSMC is effectively suppressed by si-MCP-1, a CCR2 antagonist, or MMP-2 inhibition. Threshold levels of MCP-1, MMP-2, or TGF-β1 activity trigger a feed-forward signaling mechanism that is implicated in the initiation and progression of adverse age-associated arterial wall remodeling. Intervention that suppressed this signaling loop may potentially retard age-associated adverse arterial remodeling.
Indeed, we proved that inhibition of MMP activation decelerates the age-associated arterial proinflammation and its attendant increase in arterial pressure. Chronic administration of a broad-spectrum MMP inhibitor, PD166793, via a daily gavage, to 16-month-old rats for 8 months markedly blunted the expected age-associated increases in arterial pressure. This was accompanied by the following: (1) inhibition of the age-associated increases in aortic gelatinase and interstitial collagenase activity in situ; (2) preservation of the elastic fiber network integrity; (3) a reduction of collagen deposition; (4) a reduction of monocyte chemoattractant protein 1 and transforming growth factor-beta1 activation; (5) a diminution in the activity of the profibrogenic signaling molecule SMAD-2/3 phosphorylation; (6) inhibition of proendothelin 1 activation; and (7) downregulation of expression of ets-1. Collectively, our results indicate that MMP inhibition retards age-associated arterial proinflammatory signaling, and this is accompanied by preservation of intact elastin fibers, a reduction in collagen, and blunting of an age-associated increase in blood pressure.
In addition, the vascular type Ehlers-Danlos syndrome (vEDS), a genetic disorder, is associated with increased metalloproteinase (MMP) activity, reduced collagen content in the arterial walls, and spontaneous development of lesions of varying severity in the aorta. Chronic treatment with an MMP inhibitor increases the collagen content and prevents the development of spontaneous aortic lesions. Heterozygous COL3A1-deficient mice (HT) were treated since weaning with a broad spectrum MMP inhibitor, doxycycline, added to food. At the age of 9 months MMP-9 expression was twice as high in tunica media of aortae in untreated HT, while total collagen content was 30% lower and the cumulative score of aortic lesions was 8 times higher than in wild type mice (WT). After 9 months of doxycycline treatment, MMP-9 activity, collagen content and lesions in aortae of HT were at the level of WT. In the aneurismal mouse model of collagen III haploinsufficiency, treatment with a broad spectrum MMP inhibitor started early in life normalized increased MMP activity and reduced aortic collagen content in adult and prevented development of spontaneous aortic lesions. These findings provide experimental justification for clinical evaluation of the benefit of doxycycline at least in the haploinsufficient variety of vEDS patients.
A recent study has shown the Ang II/TGF-β1/vasorin signaling relationship within VSMC with aging. In vivo studies in old (30-month-old) versus young (8-month-old) Fisher 344 Crossbred Norway Brown (FXBN) rat show that aortic transcription and translation of vasorin markedly decreases with aging. In vitro studies in early passage VSMC from old versus young aortae indicate that vasorin protein abundance is substantially reduced with aging. Ang II-associated reduction of vasorin protein abundance in young VSMC and age-associated changes in vasorin protein levels are reversed by the Ang II receptor AT1 antagonist, Losartan (Los), suggesting constitutive activation of AT1 signaling within the arterial wall with aging. Dual immunolabeling and co-immunoprecipitation demonstrate that the co-incidence and physical interaction of vasorin and TGF-β1 within VSMC are significantly decreased with aging. Importantly, exposure of young VSMC to Ang II increases p-SMAD2/3 and collagen type I production, mimicking old cells, and this effect is abolished or substantially mitigated by Los treatment, overexpression of ectopic vasorin, or exogenous recombinant human-vasorin protein. In contrast, exposure of old VSMC to Los decreases p-SMAD2/3 and collagen type I production. Thus, an imbalance of the Ang II/TGF-β1/vasorin signaling cascade, a feature of the aged arterial wall, enhances the collagen production by VSMC. Thus, maintaining the balance of vasorin/TGF-β1 signaling is a novel measure to retard adverse age-associated extracellular matrix remodeling, a determinant of arterial stiffening.
Interestingly, the cumulative effects of cellular senescence and cell loss over time in the vascular walls, similar to classical cellular replicative senescence, are considered major contributing factors to the aging proinflammation such as activated MMP-2/9. Herein, an in vitro model of calorie restriction (CR) was used to study the effects of this dietary regime on replicative senescence, cellular lifespan, MMP-2/9 activation and modulation of the SIRT1 signaling pathway in normal human diploid fibroblasts. We found that serum from calorie-restricted animals was able to delay senescence, and inactivate MMP-2/9 and significantly increase replicative lifespan in these cells, when compared to serum from ad libitum fed animals. These effects correlated with CR-mediated increases in SIRT1 and decreases in p53 expression levels. Our results demonstrate that CR can delay senescence, MMP-2/9, and increase replicative lifespan of normal human diploid fibroblasts in vitro and likely suggest that SIRT1 plays an important role in the activation of MMP-2/9 in the arterial all with aging.
Taken together, this complex local signaling loop of MCP-1/MMP-2/TGF-beta1 plays a bedrock role in the initiation and progression of age-associated arterial intimal cellularity and fibrosis and relevant vascular diseases, including aneurysm. Blockade of this vicious cycle is a potential therapeutic approach to arterial health with advancing age.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mingyi Wang其他文献
Mingyi Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mingyi Wang', 18)}}的其他基金
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
- 批准号:
7732171 - 财政年份:
- 资助金额:
$ 32.87万 - 项目类别:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
- 批准号:
8736500 - 财政年份:
- 资助金额:
$ 32.87万 - 项目类别:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
- 批准号:
7963894 - 财政年份:
- 资助金额:
$ 32.87万 - 项目类别:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
- 批准号:
8156756 - 财政年份:
- 资助金额:
$ 32.87万 - 项目类别:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
- 批准号:
8552341 - 财政年份:
- 资助金额:
$ 32.87万 - 项目类别:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
- 批准号:
10913025 - 财政年份:
- 资助金额:
$ 32.87万 - 项目类别:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
- 批准号:
8931490 - 财政年份:
- 资助金额:
$ 32.87万 - 项目类别:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
- 批准号:
9351932 - 财政年份:
- 资助金额:
$ 32.87万 - 项目类别:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
- 批准号:
10688765 - 财政年份:
- 资助金额:
$ 32.87万 - 项目类别:
Progression of Arterial Aging: the Local MCP-1/MMP-2/TGF-beta 1 Signaling Loop
动脉老化的进展:局部 MCP-1/MMP-2/TGF-beta 1 信号环路
- 批准号:
10007327 - 财政年份:
- 资助金额:
$ 32.87万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341426 - 财政年份:2024
- 资助金额:
$ 32.87万 - 项目类别:
Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
- 批准号:
2341424 - 财政年份:2024
- 资助金额:
$ 32.87万 - 项目类别:
Continuing Grant
PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政策的情绪动态
- 批准号:
10108433 - 财政年份:2024
- 资助金额:
$ 32.87万 - 项目类别:
EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
- 批准号:
MR/X032809/1 - 财政年份:2024
- 资助金额:
$ 32.87万 - 项目类别:
Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
- 批准号:
MR/X034690/1 - 财政年份:2024
- 资助金额:
$ 32.87万 - 项目类别:
Fellowship
Walkability and health-related quality of life in Age-Friendly Cities (AFCs) across Japan and the Asia-Pacific
日本和亚太地区老年友好城市 (AFC) 的步行适宜性和与健康相关的生活质量
- 批准号:
24K13490 - 财政年份:2024
- 资助金额:
$ 32.87万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovering the (R)Evolution of EurAsian Steppe Metallurgy: Social and environmental impact of the Bronze Age steppes metal-driven economy
发现欧亚草原冶金的(R)演变:青铜时代草原金属驱动型经济的社会和环境影响
- 批准号:
EP/Z00022X/1 - 财政年份:2024
- 资助金额:
$ 32.87万 - 项目类别:
Research Grant
ICF: Neutrophils and cellular senescence: A vicious circle promoting age-related disease.
ICF:中性粒细胞和细胞衰老:促进与年龄相关疾病的恶性循环。
- 批准号:
MR/Y003365/1 - 财政年份:2024
- 资助金额:
$ 32.87万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
- 批准号:
2335955 - 财政年份:2024
- 资助金额:
$ 32.87万 - 项目类别:
Standard Grant
Shaping Competition in the Digital Age (SCiDA) - Principles, tools and institutions of digital regulation in the UK, Germany and the EU
塑造数字时代的竞争 (SCiDA) - 英国、德国和欧盟的数字监管原则、工具和机构
- 批准号:
AH/Y007549/1 - 财政年份:2024
- 资助金额:
$ 32.87万 - 项目类别:
Research Grant